• LAST PRICE
    2.6500
  • TODAY'S CHANGE (%)
    Trending Down-0.0400 (-1.4870%)
  • Bid / Lots
    2.6500/ 2
  • Ask / Lots
    2.7400/ 1
  • Open / Previous Close
    2.7100 / 2.6900
  • Day Range
    Low 2.6500
    High 2.7100
  • 52 Week Range
    Low 1.9100
    High 48.7900
  • Volume
    30,792
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Monday's close: 2.69
TimeVolumeVVOS
09:32 ET2092.71
09:39 ET10002.6601
09:50 ET10002.67
09:51 ET21002.6912
10:06 ET10002.68
10:08 ET15982.6928
10:09 ET1132.6999
10:11 ET4232.6724
10:15 ET3002.6747
10:18 ET9962.66
10:20 ET2122.65
10:38 ET5002.66
10:44 ET9002.6612
10:45 ET7802.65
10:47 ET5002.6555
10:51 ET4002.67
10:54 ET6002.6812
10:56 ET1002.67
11:18 ET11002.69
11:20 ET3002.6994
11:23 ET1002.7
11:39 ET24502.69
12:19 ET4002.69
12:28 ET8912.6901
12:35 ET4372.68
12:48 ET1122.6597
01:18 ET3002.6962
01:22 ET5902.658
01:24 ET1002.6716
01:56 ET10002.67
02:38 ET1552.6504
02:54 ET1002.65
02:59 ET5002.66
03:06 ET2052.66
03:12 ET5002.65
03:28 ET2082.6546
03:44 ET15202.65
03:50 ET2002.65
04:00 ET29842.68
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesVVOS
Vivos Therapeutics Inc
12.8M
-0.4x
---
United StatesSCND
Scientific Industries Inc
10.5M
-1.1x
---
United StatesLFWD
Lifeward Ltd
20.6M
-0.8x
---
United StatesAPDN
Applied DNA Sciences Inc
1.9M
0.0x
---
United StatesNURO
NeuroMetrix Inc
7.7M
-0.6x
---
United StatesLUCY
Innovative Eyewear Inc
12.7M
-0.7x
---
As of 2024-11-05

Company Information

Vivos Therapeutics, Inc. is a medical technology company focused on developing and commercializing diagnostic and treatment methods for patients suffering from breathing and sleep issues arising from certain dentofacial abnormalities such as obstructive sleep apnea (OSA) and snoring in adults. The Company calls its solution The Vivos Method. The Vivos Method represents the first clinically effective nonsurgical, noninvasive and nonpharmaceutical solution for treating mild to severe OSA. The Vivos Method includes treatment regimens that employ the proprietary Complete Airway Repositioning and/or Expansion (CARE) appliance therapy and other modalities that alter the size, shape and position of the soft tissues that comprise a patient's upper airway and/or palate. The Vivos Method comprises various products and services, including Vivos CARE oral appliance therapy, Vivos oral appliances and therapies outside of CARE system, Vivos AireO2, and Vivos Airway Intelligence Service.

Contact Information

Headquarters
7921 Southpark Plaza,, Suite 210LITTLETON, CO, United States 80120
Phone
---
Fax
302-655-5049

Executives

Chairman of the Board, Chief Executive Officer, Co-Founder
R. Kirk Huntsman
Chief Financial Officer
Bradford Amman
Independent Director
Ralph Green
Independent Director
Anja Krammer
Independent Director
Mark Lindsay

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$12.8M
Revenue (TTM)
$14.0M
Shares Outstanding
4.8M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
7.67
EPS
$-6.98
Book Value
$0.22
P/E Ratio
-0.4x
Price/Sales (TTM)
0.9
Price/Cash Flow (TTM)
---
Operating Margin
-96.23%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.